Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,934 | -7,408 | -7,608 | -3,951 | -22,698 |
| Depreciation Amortization | 208 | 152 | 97 | 49 | 345 |
| Accounts receivable | 479 | 927 | 441 | 524 | N/A |
| Accounts payable and accrued liabilities | 586 | -2,017 | -1,472 | -1,154 | N/A |
| Other Working Capital | 1,921 | -315 | 950 | -1,285 | 3,068 |
| Other Operating Activity | 3,712 | 2,529 | 2,321 | 1,496 | 603 |
| Operating Cash Flow | $-11,028 | $-6,132 | $-5,271 | $-4,321 | $-18,682 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -293 | -98 | -68 | -22 | -124 |
| Investing Cash Flow | $-293 | $-98 | $-68 | $-22 | $-124 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 41,241 | 24,974 | N/A | N/A | N/A |
| Other Financing Activity | 193 | -20 | 0 | 0 | 2,044 |
| Financing Cash Flow | $41,434 | $24,954 | $N/A | $N/A | $2,044 |
| Exchange Rate Effect | 1,720 | -526 | -817 | -655 | -444 |
| Beginning Cash Position | 11,432 | 11,432 | 11,432 | 11,432 | 28,638 |
| End Cash Position | 43,266 | 29,630 | 5,276 | 6,435 | 11,432 |
| Net Cash Flow | $31,834 | $18,198 | $-6,156 | $-4,998 | $-17,206 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,028 | -6,132 | -5,271 | -4,321 | -18,682 |
| Capital Expenditure | -293 | -98 | -68 | -22 | N/A |
| Free Cash Flow | -11,321 | -6,230 | -5,339 | -4,343 | -18,682 |